Inventor · disambiguated record
Steven Leong
Also filed as: LEONG STEVEN · LEONG STEVEN R
39 granted patents·7 pending applications·1,189 citations·filing 1995–2025
98Inventor score
Top patents by PatentIndex Score
46 records- 0197US12064354B2Composite porous interbodies and methods of manufactureALPHATEC SPINE INC·Filed 2021·Granted Aug 20, 2024·14 cites·8 claims
- 0297US7122636B1Antibody fragment-polymer conjugates and uses of sameGENENTECH INC·Filed 2000·Granted Oct 17, 2006·134 cites·22 claims
- 0396US6133426AHumanized anti-IL-8 monoclonal antibodiesGENENTECH INC·Filed 1998·Granted Oct 17, 2000·306 cites·17 claims
- 0495US9562099B2Anti-B7-H4 antibodies and immunoconjugatesGENENTECH INC·Filed 2014·Granted Feb 7, 2017·16 cites·17 claims
- 0594US7214776B2Antibody fragment-polymer conjugates and uses of sameGENENTECH INC·Filed 2005·Granted May 8, 2007·26 cites·20 claims
- 0693US11286302B2Anti-B7-H4 antibodies and immunoconjugatesGENENTECH INC·Filed 2018·Granted Mar 29, 2022·4 cites·36 claims
- 0793US7507405B2Antibody fragment-polymer conjugates and uses of sameGENENTECH INC·Filed 2006·Granted Mar 24, 2009·19 cites·6 claims
- 0892US10059768B2Anti-B7-H4 antibodies and immunoconjugatesGENENTECH INC·Filed 2015·Granted Aug 28, 2018·9 cites·19 claims
- 0992US9951133B2Anti-CD33 antibodies and immunoconjugatesGENENTECH INC·Filed 2016·Granted Apr 24, 2018·12 cites·51 claims
- 1092US7842789B2Antibody fragment-polymer conjugates and uses of sameGENENTECH INC·Filed 2008·Granted Nov 30, 2010·14 cites·36 claims
- 1192US6468532B1Methods of treating inflammatory diseases with anti-IL-8 antibody fragment-polymer conjugatesGENENTECH INC·Filed 1999·Granted Oct 22, 2002·95 cites·23 claims
- 1291US11230600B2Anti-B7-H4 antibodies and immunoconjugatesGENENTECH INC·Filed 2018·Granted Jan 25, 2022·3 cites·23 claims
- 1391US7094875B2Co-stimulatory polypeptidesMAXYGEN INC·Filed 2001·Granted Aug 22, 2006·24 cites·53 claims
- 1491US7005504B2Antibody fragment-peg conjugatesGENENTECH INC·Filed 2000·Granted Feb 28, 2006·30 cites·15 claims
- 1590US10940019B2Intervertebral cage with porosity gradientALPHATEC SPINE INC·Filed 2018·Granted Mar 9, 2021·18 cites·17 claims
- 1690US10150813B2Anti-B7-H4 antibodies and immunoconjugatesGENENTECH INC·Filed 2014·Granted Dec 11, 2018·12 cites·55 claims
- 1790US7612170B2Co-stimulatory polypeptidesMAXYGEN INC·Filed 2006·Granted Nov 3, 2009·16 cites·21 claims
- 1890US6117980AHumanized anti-IL-8 monoclonal antibodiesGENENTECH INC·Filed 1997·Granted Sep 12, 2000·85 cites·19 claims
- 1989US5707622AMethods for treating ulcerative colitisGENENTECH INC·Filed 1995·Granted Jan 13, 1998·49 cites·7 claims
- 2089US5702946AAnti-IL-8 monoclonal antibodies for treatment of inflammatory disordersGENENTECH INC·Filed 1995·Granted Dec 30, 1997·63 cites·12 claims
- 2187US10501545B2Anti-CLL-1 antibodies and methods of useGENENTECH INC·Filed 2016·Granted Dec 10, 2019·6 cites·31 claims
- 2287US8147830B2Antibody fragment-polymer conjugates and uses of sameHSEI VANESSA·Filed 2010·Granted Apr 3, 2012·9 cites·3 claims
- 2386US12496196B2Vertebral body replacement and insertion deviceALPHATEC SPINE INC·Filed 2023·Granted Dec 16, 2025·2 cites·19 claims
- 2486US5677426AAnti-IL-8 antibody fragmentsGENENTECH INC·Filed 1995·Granted Oct 14, 1997·45 cites·6 claims
- 2585US6025158ANucleic acids encoding humanized anti-IL-8 monoclonal antibodiesGENENTECH INC·Filed 1998·Granted Feb 15, 2000·57 cites·18 claims
- 2684US5686070AMethods for treating bacterial pneumoniaGENENTECH INC·Filed 1995·Granted Nov 11, 1997·46 cites·5 claims
- 2781US12491083B2Composite porous interbodies and methods of manufactureALPHATEC SPINE INC·Filed 2024·Granted Dec 9, 2025·0 cites·20 claims
- 2880US12281165B2Anti-B7-H4 antibodies and immunoconjugatesGENENTECH INC·Filed 2022·Granted Apr 22, 2025·0 cites·20 claims
- 2980US2025297011A1Anti-B7-H4 Antibodies and ImmunoconjugatesGENENTECH INC·Filed 2025·Application pending·0 cites
- 3079US12134649B2Anti-B7-H4 antibodies and immunoconjugatesGENENTECH INC·Filed 2021·Granted Nov 5, 2024·0 cites·20 claims
- 3175US10556951B2Anti-CD33 antibodies and immunoconjugatesGENENTECH INC·Filed 2018·Granted Feb 11, 2020·1 cites·39 claims
- 3275US6458355B1Methods of treating inflammatory disease with anti-IL-8 antibody fragment-polymer conjugatesGENENTECH INC·Filed 1998·Granted Oct 1, 2002·50 cites·34 claims
- 3374US7183376B2Variant B7 co-stimulatory moleculesMAXYGEN INC·Filed 2001·Granted Feb 27, 2007·6 cites·30 claims
- 3468US2023172728A1Intervertebral Cage with Porosity GradientALPHATEC SPINE INC·Filed 2023·Application pending·0 cites
- 3565US11596527B2Intervertebral cage with porosity gradientALPHATEC SPINE INC·Filed 2021·Granted Mar 7, 2023·0 cites·20 claims
- 3664US2010261660A1Novel co-stimulatory moleculesMAXYGEN INC·Filed 2006·Application pending·0 cites
- 3763US11466087B2Anti-CLL-1 antibodies and methods of useGENENTECH INC·Filed 2019·Granted Oct 11, 2022·0 cites·17 claims
- 3861US12396769B2Bone fixation systems and methodsALPHATEC SPINE INC·Filed 2021·Granted Aug 26, 2025·0 cites·8 claims
- 3960US6870033B1Antibody fragment-polymer conjugates and humanized anti-IL-8 monoclonal antibodiesGENENTECH INC·Filed 1998·Granted Mar 22, 2005·18 cites·10 claims
- 4059US8652468B2Methods of binding TNF-α using anti-TNF-α antibody fragment-polymer conjugatesHSEI VANESSA·Filed 2012·Granted Feb 18, 2014·0 cites·19 claims
- 4157US2017239366A1Anti-b7-h4 antibodies and immunoconjugatesGENENTECH INC·Filed 2016·Application pending·0 cites
- 4256US7115712B1Cytokine polypeptidesMAXYGEN INC·Filed 2000·Granted Oct 3, 2006·0 cites·12 claims
- 4354US2006264615A1Cytokine polypeptides and nucleic acidsMAXYGEN INC·Filed 2006·Application pending·0 cites
- 4453US2005084913A1Novel tumor-associated antigensMAXYGEN INC·Filed 2004·Application pending·0 cites
- 4551US11154338B2Bone fixation systems and methodsALPHATEC SPINE INC·Filed 2017·Granted Oct 26, 2021·0 cites·16 claims
- 4648US2005154189A1Novel co-stimulatory moleculesMAXYGEN INC·Filed 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Steven Leong files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →